This topic contains a solution. Click here to go to the answer

Author Question: A patient comes to the clinic and asks the primary care NP about using a newly developed formulation ... (Read 28 times)

lb_gilbert

  • Hero Member
  • *****
  • Posts: 588
A patient comes to the clinic and asks the primary care NP about using a newly developed formulation of the drug the patient has been taking for a year. When deciding whether or not to prescribe this formulation, the NP should:
 
  a. tell the patient that when postmarketing data is available, it will be considered.
  b. review the pharmaceutical company promotional materials about the new medication.
  c. prescribe the medication if it is less expensive than the current drug formulation.
  d. prescribe the medication if the new drug is available in an extended-release form.

Question 2

A patient who has been taking propranolol for 6 months reports having nocturnal cough and shortness of breath. The primary care NP should:
 
  a. tell the patient to stop taking the medication.
  b. obtain serum drug levels to monitor for toxicity of this medication.
  c. instruct the patient to increase activity and exercise to counter these side effects.
  d. contact the patient's cardiologist to discuss changing to a selective B-blocker.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

isabelt_18

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

A
About 6 to 12 months of postmarketing experience can yield information about drug efficacy and side effects, so patients should be cautioned to wait for these data. Drug company promotional materials have biased information. Most new drugs are more expensive, and costs alone should not determine drug choice. Extended-release forms are often more expensive.

Answer to Question 2

D
Nocturnal cough and shortness of breath may be a side effect of propranolol, which can cause bronchospasm because it is a nonselective -blocker. The NP should discuss a selective B-blocker with the patient's cardiologist. -Blockers should never be stopped abruptly. Bradycardia and hypotension are signs of toxicity. Increasing activity would not counter these side effects if bronchospasm is the cause.




lb_gilbert

  • Member
  • Posts: 588
Reply 2 on: Jul 24, 2018
YES! Correct, THANKS for helping me on my review


ryansturges

  • Member
  • Posts: 338
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

For a complete list of videos, visit our video library